Schedule 13D ownership disclosure

Vera Therapeutics Inc

Security class unavailable · CUSIP: 92337R101

Event date: 2023-07-18

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
4.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-23-201784
Form type
SC 13D/A
Filer
Carlyle Group Inc.
CIK
CIK 1527166
Filed
Aug 02, 2023
Reporting period
Jul 18, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub